Connective Tissue Peptides TRIZ Cases

A modified collagen scaffold incorporates S-nitroso groups to deliver controlled nitric oxide release.

Recombinant fibronectin mimetics stimulate cell spreading and migration, resolving infectious risks from plasma-derived proteins.

Segmented TSR peptides drive neural differentiation, resolving the trade-off between stem cell expansion efficiency and specific lineage production.

A peptide probe maintains a stable single-stranded conformation to detect pathological collagen.

Optimized artificial peptides induce mineral precipitation on surfaces and tissues.

Hypoxic culture generates embryonic protein-rich extracellular matrix compositions.

Adding fibroin fractions to collagen hydrogels resolves insufficient mechanical strength and unpredictable reabsorption.

A beta-sheet nanofiber composition integrates bioactive proteins via peptide self-assembly to create modular biomaterials.

Cathepsin-S cleaved Nidogen-1 fragments serve as biomarkers for non-invasive cancer diagnosis and anti-cancer drug efficacy evaluation.

Nidogen-1 G2 domain variants form nanoparticles delivering therapeutic agents to CXCR4-expressing cells, reducing toxicity to non-target organs.

Targeted matrilin-3 antibodies deliver therapeutic payloads to growth plates, resolving systemic risks of skeletal disorder treatments.

Triple helix coil scaffolds fuse heterologous binding domains into trimeric complexes that reduce mitogenic effects while maintaining high affinity.

Acid hydrolysis converts chicken sternum into odorless collagen peptides, eliminating enzymatic production costs and strong odors.

Modular synthetic proteins neutralize viral pathogens while bypassing costly mammalian cell culture systems required for monoclonal antibodies.

Cross-linked collagen scaffolds coat implantable glucose sensors to reduce inflammation and fibrosis while maintaining sensor sensitivity.

Monoclonal antibodies detect CRP and ApoE peptide fragments to quantify protease activity, providing a non-invasive index of plaque rupture risk.

Knob and hole mutations in IgG1 Fc domains direct heterodimeric NC-1-Fc assembly for therapeutic use.

Solvent-based purification eliminates nucleic acid contamination and reduces processing time compared to inverse transition cycling.

Thiol-Michael addition replaces photopolymerization to eliminate network inhomogeneity and cell viability loss.

Adjusting extracellular matrix average diameter controls three-dimensional tissue rigidity for drug screening models.

Enzymatic removal of sialic acid from porcine plasma fibronectin creates a safe substrate that mimics human glycosylation without cancer metastasis risks.

A porous particulate shell prevents gelatin microsphere aggregation while enabling controlled drug release via steric stabilization.

Arginine substitutions in the BoNT/A protease domain reduce neutralizing antibody generation while maintaining high catalytic activity.

Covalent cyclic peptide ligands on polymer scaffolds improve endothelial cell attachment while reducing non-specific binding to other cell types.

Purified jellyfish collagen forms stable hydrogels through controlled mixing and incubation with neutralization buffers.

Xaa-Gly-Asp peptides trigger angiopoietin-1 release to prevent vascular leakage without inhibiting existing blood supply.

Engineered bacterial secretion systems transport recombinant silk proteins through periplasmic and outer membrane signal sequences.

Solution-phase ESR detection using paramagnetic probe molecules eliminates surface-related interference in complex biological mediums.

A recombinant polypeptide adsorbs to cultivation surfaces to support pluripotent stem cell proliferation without chemical immobilization.

Antibodies bind asprosin epitopes to modulate adipose mass, resolving obesity treatment gaps in genetic defects like Neonatal Progeroid Syndrome.

Carbohydrate recognition domains enable one-step purification of recombinant collagen, eliminating prion risks from animal sources.

Extracellular ActRII chimeras fused to Fc domains promote lean mass and bone density while reducing side effects from existing erythropoietin therapies.

Small Hepatitis B virus X-protein peptide targets connexin43 on hypoxic cells, reducing off-target toxicity and improving therapeutic efficacy.

Tetrazine-norbornene click chemistry forms biocompatible hydrogels, resolving side reaction complexity and cytotoxicity while maintaining structural integrity.

Culturing mesenchymal stem cells in recombinant gelatin liquid medium inhibits adipocyte differentiation, avoiding complex peptide steps.

Exogenous P4H and LH3 enzymes target plant compartments to ensure correct hydroxylation, resolving instability at body temperatures.

FN3 domain CARs replace unstable scFv fragments to reduce immunogenicity while maintaining high binding affinity.

Selective chemical modification of methionine side chains tunes the lower critical solution temperature without complex biotechnological procedures.

A trimeric antigen binding molecule uses a human cartilage matrix protein domain to form stable coiled-coil structures.

Inhibits cell adhesion molecules to control aggregate diameter, resolving mechanical stress and nutrient supply issues in pluripotent stem cell culture.

Collagen mimetic peptides physically bind to collagen molecules to enable functional conjugation without toxic chemical reactions.

Micelle-forming surfactants bind lipopolysaccharides in gelatin solutions below their cloud point, preserving viscosity and gel strength without hydrolysis.

Genetically modified rodents carrying the Col27a1 mutation replicate human Steel Syndrome features.

An aqueous gelatin composition rapidly gelatinizes at 27°C to support fragile cell sheets during handling.

A pretreatment method solubilizes non-denatured type II collagen using acid buffers and enzymatic digestion for subsequent detection.

Crosslinked bullfrog skin collagen matrix resolves thermal instability and rapid degradation to improve wound closure rates.

Incorporating reactive residues into bacterial collagen sequences enables site-specific cross-linking without post-translational modification.